Analysis of numbers of repeated units in R2 region among varicella-zoster virus strains

Journal of Dermatological Science

Volumn 31, Issue 2, 2003, Pages 129-133

  Yoshida, Masami ^a   Tamura, Takahiro ^b   Miyasaka, Keiichi ^a   Shimizu, Akiko ^a   Ohashi, Norio ^a   Itoh, Masatoshi ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Phenotype; R2 repeated structure; Variable number of tandem repeat; Varicella zoster virus

Indexed keywords

ACICLOVIR; VALACICLOVIR; VIRUS DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG EFFECT; FEMALE; GENE AMPLIFICATION; HERPES ZOSTER; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT; VARICELLA ZOSTER VIRUS; VIRUS STRAIN; VIRUS VIRULENCE;

ACYCLOVIR; ANTIVIRAL AGENTS; GENOME, VIRAL; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; JAPAN; PHENOTYPE; TANDEM REPEAT SEQUENCES; VALINE;

EID: 0037381143     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(02)00147-0     Document Type: Article

References (19)

1. Straus S.E., Hay J., Smith H., Owens J. Genome differences among varicella-zoster isolates. J. Gen. Virol. 64:1983;1031-1041.
2. Casey T.A., Ruyechan W.T., Flora M.N., Reinhold W., Straus S.E., Hay J. Fine mapping and sequencing of a variable segment in the inverted repeat region of varicella-zoster virus DNA. J. Virol. 54:1985;639-642.
3. Davison A.J., Scott J.E. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1986;1759-1816.
4. Hondo R., Yogo Y. Strain variation of R5 direct repeats in the right-hand portion of the long unique segment of varicella-zoster virus DNA. J. Virol. 62:1988;2916-2921.
5. Kinoshita H., Hondo R., Taguchi F., Yogo Y. Variation of R1 repeated sequence present in open reading frame 11 of varicella-zoster virus strains. J. Virol. 62:1988;1097-1100.
6. Kinchington P.R., Remenick J., Ostorove J.M., Straus S.E., Ruyechan W., Hay J. Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base pair repeat sequence has homology to herpes simplex virus glycoprotein C. J. Virol. 59:1986;660-668.
7. Takada M., Suzutani T., Yoshida I., Matoba M., Azuma M. Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region. J. Clin. Microbiol. 33:1995;658-660.
8. Hayakawa Y., Yamamoto T., Yamanishi K., Takahashi M. Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease Hpa I. J. Gen. Virol. 67:1986;1817-1829.
9. Ida M., Kageyama S., Sato H., Kamiyama T., Toyomoto T., Ozaki T., et al. Characterization of acyclovir susceptibility and genetic stability of varicella-zoster viruses isolated during acyclovir therapy. J. Dermatol. Sci. 23:2000;63-72.
10. Yoshida M., Tamura T., Hiruma M. Analysis of strain variation of R1 repeated structure in varicella-zoster virus DNA by polymerase chain reaction. J. Med. Virol. 58:1999;76-78.
11. Mori C., Takahara R., Toriyama T., Nagai T., Takahashi M., Yamanishi K. Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis. J. Infect. Dis. 178:1998;35-38.
12. Herold B.C., WuDunn D., Soltys N., Spear P.G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65:1991;1090-1098.
13. Friedman H.M., Cohen G.H., Eisenberg R.J., Seidel C.A., Cines D.B. Glycoprotein C of herpes simplex virus 1 acts for the complement component on infected cells. Nature. 309:1984;633-635.
14. Moffat J.F., Zerboni L., Kinchington P.R., Grose C., Kaneshima H., Arvin A.M. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 72:1998;965-974.
15. Kyo K., Parkes M., Takei Y., Nishimori H., Vyas P., Satsangi J., et al. Association of ulcerative colitis with rare VNTR alles of the human intestinal mucin gene, MUC3. Hum. Mol. Genet. 8:1999;307-311.
16. Umene K. Herpesvirus - genetic variability and recombination. 1998;192-193 Touka Shobou, Fukuoka.
17. Weller S., Blum M.R., Doucette M., Cederberg D.M., de Miranda P., Smiley M.L. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clin. Pharmacol. Ther. 54:1993;595-605.
18. Boyd M.R., Bacon T.H., Sutton D., Cole M. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl) guanine (BRL-39123) in cell culture. Antimicrob. Agents Chemother. 31:1987;1238-1242.
19. Cohen J.I., Seidel K.E. Absence of varicella-zoster virus (VZV) glycoprotein V does not alter growth of in vitro or sensitivity to heparin. J. Gen. Virol. 75:(Pt 11):1994;3087-3093.